Search Results - Butowski, Nicholas A
- Showing 1 - 20 results of 32
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
The Development of Reduced Diffusion Following Bevacizumab Therapy Identifies Regions of Recurrent Disease in Patients with High-grade Glioma by Barajas, Ramon F., Butowski, Nicholas A., Phillips, Joanna J., Aghi, Manish K., Berger, Mitchel S., Chang, Susan M., Cha, Soonmee
Published 2016Text -
6
-
7
Assessment of perfusion MRI-derived parameters in evaluating and predicting response to antiangiogenic therapy in patients with newly diagnosed glioblastoma by Essock-Burns, Emma, Lupo, Janine M., Cha, Soonmee, Polley, Mei-Yin, Butowski, Nicholas A., Chang, Susan M., Nelson, Sarah J.
Published 2011Text -
8
Evaluation of diffusion parameters as early biomarkers of disease progression in glioblastoma multiforme(†) by Khayal, Inas S., Polley, Mei-Yin C., Jalbert, Llewellyn, Elkhaled, Adam, Chang, Susan M., Cha, Soonmee, Butowski, Nicholas A., Nelson, Sarah J.
Published 2010Text -
9
-
10
Phase I Study of RO4929097 with Bevacizumab in Patients with Recurrent Malignant Glioma by Pan, Edward, Supko, Jeffrey G., Kaley, Thomas J., Butowski, Nicholas A., Cloughesy, Timothy, Jung, Jinkyu, Desideri, Serena, Grossman, Stuart, Ye, Xiaobu, Park, Deric M.
Published 2016Text -
11
Phase II trial of 7 days on/7 days off temozolmide for recurrent high-grade glioma by Han, Seunggu J., Rolston, John D., Molinaro, Annette M., Clarke, Jennifer L., Prados, Michael D., Chang, Susan M., Berger, Mitchel S., DeSilva, Ashley, Butowski, Nicholas A.
Published 2014Text -
12
The Effect of Timing of Concurrent Chemoradiation in Patients With Newly Diagnosed Glioblastoma by Han, Seunggu J., Rutledge, William C., Molinaro, Annette M., Chang, Susan M., Clarke, Jennifer L., Prados, Michael D., Taylor, Jennie W., Berger, Mitchel S., Butowski, Nicholas A.
Published 2015Text -
13
Impact of Timing of Concurrent Chemoradiation for Newly Diagnosed Glioblastoma: A Critical Review of Current Evidence by Han, Seunggu J., Englot, Dario J., Birk, Harjus, Molinaro, Annette M., Chang, Susan M., Clarke, Jennifer L., Prados, Michael D., Taylor, Jennie W., Berger, Mitchel S., Butowski, Nicholas A.
Published 2015Text -
14
A single-institution phase II trial of radiation, temozolomide, erlotinib, and bevacizumab for initial treatment of glioblastoma by Clarke, Jennifer L., Molinaro, Annette M., Phillips, Joanna J., Butowski, Nicholas A., Chang, Susan M., Perry, Arie, Costello, Joseph F., DeSilva, Ashley A., Rabbitt, Jane E., Prados, Michael D.
Published 2014Text -
15
Phase-2 Trial of palbociclib in adult patients with recurrent RB1-positive Glioblastoma by Taylor, Jennie W., Parikh, Mili, Phillips, Joanna J., James, C. David, Molinaro, Annette M., Butowski, Nicholas A., Clarke, Jennifer L., Oberheim-Bush, Nancy Ann, Chang, Susan M., Berger, Mitchel S., Prados, Michael
Published 2018Text -
16
Attitudes toward fertility and fertility preservation in women with glioma by Stiner, Rachel K, Clarke, Jennifer L, Sinha, Nikita, Chan, Jessica, Letourneau, Joseph M, Niemasik, Erin E, Rabbitt, Jane E, Chang, Susan M, Butowski, Nicholas A, Prados, Michael D, Rosen, Mitchell P
Published 2019Text -
17
Phase II trial of pazopanib (GW786034), an oral multi-targeted angiogenesis inhibitor, for adults with recurrent glioblastoma (North American Brain Tumor Consortium Study 06-02) by Iwamoto, Fabio M., Lamborn, Kathleen R., Robins, H. Ian, Mehta, Minesh P., Chang, Susan M., Butowski, Nicholas A., DeAngelis, Lisa M., Abrey, Lauren E., Zhang, Wei-Ting, Prados, Michael D., Fine, Howard A.
Published 2010Text -
18
A single institution retrospective analysis on survival based on treatment paradigms for patients with anaplastic oligodendroglioma by Bush, Nancy Ann Oberheim, Young, Jacob S., Zhang, Yalan, Dalle Ore, Cecilia L., Molinaro, Annette M., Taylor, Jennie, Clarke, Jennifer, Prados, Michael, Braunstein, Steve E., Raleigh, David R., Chang, Susan M., Berger, Mitchel S., Butowski, Nicholas A.
Published 2021Text -
19
A randomized controlled phase III study of VB-111 combined with bevacizumab vs bevacizumab monotherapy in patients with recurrent glioblastoma (GLOBE) by Cloughesy, Timothy F, Brenner, Andrew, de Groot, John F, Butowski, Nicholas A, Zach, Leor, Campian, Jian L, Ellingson, Benjamin M, Freedman, Laurence S, Cohen, Yael C, Lowenton-Spier, Noa, Rachmilewitz Minei, Tamar, Fain Shmueli, Shifra, Wen, Patrick Y
Published 2020Text -
20
Heat-shock protein peptide complex–96 vaccination for recurrent glioblastoma: a phase II, single-arm trial by Bloch, Orin, Crane, Courtney A., Fuks, Yelena, Kaur, Rajwant, Aghi, Manish K., Berger, Mitchel S., Butowski, Nicholas A., Chang, Susan M., Clarke, Jennifer L., McDermott, Michael W., Prados, Michael D., Sloan, Andrew E., Bruce, Jeffrey N., Parsa, Andrew T.
Published 2014Text